Review began 05/04/2022 review ended 06/22/2022 published 06/23/2022 © copyright

HIGHLIGHTS

• who: Ekaterina, Proskuriakova and Anwar, Khedr from the Internal Medicine, Mount Sinai Hospital, Chicago, USA Internal Medicine, Tanta University Faculty of Medicine have published the Article: Review began 05/04/2022 Review ended 06/22/2022 Published 06/23/2022 u00a9 Copyright, in the Journal: (JOURNAL) of June/23,/2022
• what: The main reason for this type of cancer, which is accountable for 70-90% of gallbladder cancer, is a history of choledocholithiasis. The study showed improvement in mPFS in the placebo group (1.4 months) and the ivosidenib group (2.7 months), with a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.